Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.03
+0.03 (0.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TAK.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Takeda Pharmaceutical.

Recommendation Trends

Rating Jan '23Feb '23Mar '23Apr '23May '23
Strong Buy 00110
Buy 11110
Hold 00000
Sell 00000
Strong Sell 00000
Total 11220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
TD Cowen
TD Cowen
Buy
Maintains
$30$20
Buy Maintains $30$20 +53.49% May 16, 2023
TD Cowen
TD Cowen
Buy
Maintains
$24$30
Buy Maintains $24$30 +130.24% Apr 4, 2023
B of A Securities
B of A Securities
Strong Buy
Upgrades
$20
Strong Buy Upgrades $20 +53.49% Mar 16, 2023
Cowen & Co.
Cowen & Co.
Buy
Upgrades
$21$24
Buy Upgrades $21$24 +84.19% Jul 19, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
4,306.00B
from 4,263.76B
Increased by 0.99%
Revenue Next Year
4,378.64B
from 4,306.00B
Increased by 1.69%
EPS This Year
94.91
from 45.58
Increased by 108.22%
EPS Next Year
148.46
from 94.91
Increased by 56.43%
Year 20192020202120222023202420252026
Revenue
3,291.19B3,197.81B3,569.01B4,027.48B4,263.76B4,306.00B4,378.64B4,469.69B
Revenue Growth
56.93%-2.84%11.61%12.85%5.87%0.99%1.69%2.08%
EPS
14.13119.4872.94100.9745.5894.91148.46196.51
EPS Growth
-79.80%745.88%-38.96%38.44%-54.86%108.22%56.43%32.36%
Forward PE
-----0.140.090.07
No. Analysts -----181715
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 4.6T 4.8T 4.9T
Avg 4.3T 4.4T 4.5T
Low 3.9T 3.9T 3.9T

Revenue Growth

Revenue Growth 202420252026
High
8.5%
10.5%
13.0%
Avg
1.0%
1.7%
2.1%
Low
-8.6%
-8.8%
-11.6%

EPS Forecast

EPS 202420252026
High 185.85 234.17 325.30
Avg 94.91 148.46 196.51
Low 40.18 48.02 58.80

EPS Growth

EPS Growth 202420252026
High
307.7%
146.7%
119.1%
Avg
108.2%
56.4%
32.4%
Low
-11.8%
-49.4%
-60.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.